CNVIF (Conavi Medical) Tariff Resilience Score: 6/10 (As of Jul. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CNVIF Conavi Medical Corp CNVIF
4 GF Score
Price $0.13
! 5 Warning Signs
View Full Analysis

What is Conavi Medical Tariff Resilience Score?

Conavi Medical CNVIF +8.91% 4 Tariff Resilience Score is 6 as of Jul. 28, 2026. GuruFocus rates CNVIF with a GF Score™ of 4/100. The stock has 5 warning signs investors should review. Among 830 Medical Devices & Instruments companies, Conavi Medical ranks better than 90.96% on this metric.

Conavi Medical has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Conavi Medical has Moderate exposure with a balanced import/export profile. Some historical tariff impacts, but mitigated through pricing strategies and alternative suppliers. Industry has some exemptions.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Conavi Medical might have Average Resilient.

Conavi Medical  (OTCPK:CNVIF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Conavi Medical Tariff Resilience Score Related Terms

CNVIF vs ABT, SYK, MDT: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Conavi Medical's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Conavi Medical Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conavi Medical's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Conavi Medical's Tariff Resilience Score falls into.


CNVIF
4GF Score
Conavi Medical Corp CNVIF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Conavi Medical (CNVIF) has a Tariff Resilience Score of 6 as of Jul. 28, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Conavi Medical ranks #75 out of 830 companies in the Medical Devices & Instruments industry, placing it in the top 9%.
Is Conavi Medical's Tariff Resilience Score too high?
Conavi Medical's current Tariff Resilience Score is 6. Based on the distribution chart, Conavi Medical ranks #75 out of 830 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Conavi Medical has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Conavi Medical's Tariff Resilience Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Conavi Medical ranks #75 out of 830 companies for Tariff Resilience Score. This places Conavi Medical in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Conavi Medical's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conavi Medical stock overvalued right now?
Conavi Medical (CNVIF) has a current Tariff Resilience Score of 6. The current Tariff Resilience Score is 6. Conavi Medical's overall GF Score™ is 4/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Conavi Medical (CNVIF), the current Tariff Resilience Score is 6 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Conavi Medical Business Description

Other Exchanges CNVI:Canada
Address 293 Lesmill Road, Toronto, ON, CAN, M3B 2V1
Conavi Medical Corp is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its Novasight Hybrid System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries.
4GF Score

Get the complete analysis for CNVIF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.13
Price